Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

by Altvater, B., Angenendt, L., Berdel, A.F, Berdel, W.E, Bornhauser, M., Gerwing, M., Hartmann, W., Hemmerle, T., Hescheler, D., Kessler, T., Lenz, G., Matasci, M., Mikesch, J.-H, Neri, D., Rollig, C., Rossig, C., Rueter, B., Ruhnke, L., Schafers, M., Scheller, A., Schliemann, C., Stelljes, M., Wermke, M., Wethmar, K.
Published 2022